Serum interleukin-6 levels as an early marker of therapeutic response to UVB radiation and topical steroids in psoriatic patients. [electronic resource]
- International journal of clinical & laboratory research 1994
- 122-3 p. digital
Publication Type: Letter
0940-5437
10.1007/BF02593914 doi
Adult Aged Aged, 80 and over Betamethasone--therapeutic use Biomarkers--blood Combined Modality Therapy Female Humans Interleukin-6--blood Middle Aged Psoriasis--therapy Salicylates--therapeutic use Salicylic Acid Severity of Illness Index Ultraviolet Therapy